2008
DOI: 10.1186/1742-4682-5-24
|View full text |Cite
|
Sign up to set email alerts
|

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary

Abstract: Background and hypothesis: Based on neurochemical and genetic evidence, we suggest that both prevention and treatment of multiple addictions, such as dependence to alcohol, nicotine and glucose, should involve a biphasic approach. Thus, acute treatment should consist of preferential blocking of postsynaptic Nucleus Accumbens (NAc) dopamine receptors (D1-D5), whereas long term activation of the mesolimbic dopaminergic system should involve activation and/or release of Dopamine (DA) at the NAc site. Failure to d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
105
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
4

Relationship

3
7

Authors

Journals

citations
Cited by 165 publications
(110 citation statements)
references
References 65 publications
4
105
0
1
Order By: Relevance
“…From an affective neuroscience perspective, it seems that the brain's mesolimbic system ("reward system" -linked to dopamine pathways) is crucial to the functioning of the drive system, regulating the pleasure response, i.e., the hedonic impact of the stimuli (Berridge & Kringelbach, 2008;Blum et al, 2008;Depue & Morrone-Strupinsky, 2005;Esch & Stefano, 2004). Further, it has been suggested that some genetic variations are also important in the function of the reward system, especially when linked to certain environmental experiences (Blum et al, 2008).…”
Section: The Drive Systemmentioning
confidence: 99%
“…From an affective neuroscience perspective, it seems that the brain's mesolimbic system ("reward system" -linked to dopamine pathways) is crucial to the functioning of the drive system, regulating the pleasure response, i.e., the hedonic impact of the stimuli (Berridge & Kringelbach, 2008;Blum et al, 2008;Depue & Morrone-Strupinsky, 2005;Esch & Stefano, 2004). Further, it has been suggested that some genetic variations are also important in the function of the reward system, especially when linked to certain environmental experiences (Blum et al, 2008).…”
Section: The Drive Systemmentioning
confidence: 99%
“…We concluded that this seminal work will provide important information that may ultimately lead to significant improvement in the recovery of individuals with psychostimulant and polydrug abuse problems, specifically those with genetically induced dopamine deficiency. Based on this small sample size, we are proposing that with necessary large populations supporting these initial results it is possible incorporate a safe, nonaddicting, natural dopaminergic receptor agonist that potentially up-regulates instead of downregulates dopaminergic receptors, preferably the D2 subtype (Blum et al, 2008).…”
Section: Reward Circuitry Opioid-dopaminergic Connectivity As a Theramentioning
confidence: 99%
“…Specifically, Blum et al [34] proposed that D2 receptor stimulation can be accomplished via the use of KB220Z [35], a complex therapeutic nutraceutical formulation that potentially induces DA release, causing the same induction of D2-directed mRNA and thus proliferation of D2 receptors in the human. This proliferation of D2 receptors in turn will induce the attenuation of craving behavior.…”
Section: Support For Reward Deficiency Syndrome (Rds) As the "True Phmentioning
confidence: 99%